FABTECHNSEFABTECH TECHNOLOGIES LTD· Healthcare Equipment & SuppliesHighNeutral
Announced Wed, 28 Oct, 2026 · 20:51 IST

Q2 FY27 revenue up 23%, PAT down 47% after exceptional TSA sale gain

Revenue Growth 20pctExceptional ItemNegative Operating CashflowResults View source PDFExplain this filing

FABTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.2%Reaction day
₹126.00
prior close
₹123.12
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-3.8% vs market
Medical Equipment & Supplies peers, median of 12sector+0.6%-3.8% vs sector

On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-2.5
15m
-2.5
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.2+0.7-3.8+0.6-3.8
Next day
-0.5pendingpending-1.0+0.5
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q2 FY27 revenue was Rs 9,208.76 lakh, up 23% from Rs 7,498.41 lakh, while net profit fell 47% to Rs 1,502.48 lakh (EPS Rs 3.38). Half-year revenue rose 37% to Rs 16,707.17 lakh but profit slipped 12% to Rs 1,923.51 lakh. A Rs 835.25 lakh exceptional gain on selling its TSA stake supported profit. Operating cash flow was negative Rs 4,114.28 lakh. Review report was unmodified.

Likely market impact

Revenue growth is strong, but profit fell and relied on a one-off sale gain, with negative operating cash flow a concern.